|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Operating Activities: | |||||
| Net income | |||||
| Adjustments to reconcile net income to net cash provided from operating activities: | |||||
| Depreciation and amortization | |||||
| Provision for credit losses | |||||
| Provision for other credit losses | |||||
| Discount on notes receivable | |||||
| Equity based compensation and restricted stock vested | |||||
| Amortization of debt issuance costs | |||||
| Fair value adjustment on warrants | |||||
| Impairment losses on long-lived assets | |||||
| Gain on sale of fixed assets | |||||
| Loss on extinguishment of line of credit | |||||
| Deferred income taxes | |||||
| Changes in operating assets and liabilities: | |||||
| Notes receivable | |||||
| Other receivables | |||||
| Prepaid expenses and other assets | |||||
| Merchant accounts payable | |||||
| Other payables | |||||
| Accrued and other liabilities | |||||
| Deferred revenue | |||||
| Operating leases | |||||
| Net Cash Provided from Operating Activities | |||||
| Investing Activities: | |||||
| Purchases and originations of notes receivable, net of proceeds from repayments | |||||
| Purchase of property and equipment | |||||
| Internally developed intangible asset additions | |||||
| Net Cash Used for Investing Activities | |||||
| Financing Activities: | |||||
| Proceeds from line of credit | |||||
| Payments to line of credit | |||||
| Payments of debt issuance costs | |||||
| Payment of debt extinguishment costs | |||||
| Proceeds from stock option exercises | |||||
| Stock subscriptions collected related to stock option exercises | |||||
| Proceeds from warrant exercises | |||||
| Repurchase of common stock | |||||
| Net Cash Used for Financing Activities | |||||
| Effect of exchange rate changes on cash | |||||
| Net increase in cash, cash equivalents, and restricted cash | |||||
| Cash, cash equivalents, and restricted cash, beginning of period | |||||
| Cash, cash equivalents, and restricted cash, end of period | |||||
| Noncash investing and financing activities: | |||||
| Lease liabilities arising from obtaining right-of-use assets | |||||
| Issuance of warrants | |||||
| Conversion of accrued profit-sharing incentive plan liabilities to stockholders' equity | |||||
| Conversion of warrant liabilities to stockholders' equity | |||||
| Supplementary disclosures: | |||||
| Interest paid | |||||
| Income taxes paid: | |||||
| Federal income taxes paid | |||||
| State income taxes paid | |||||
| Foreign income taxes paid | |||||
| Total income taxes paid | |||||
Loading...